Improving the managed introduction of new medicines: sharing experiences to aid authorities across Europe

Wojciech Matusewicz, Brian Godman, Hanne Bak Pedersen, Jurij Fürst, Jolanta Gulbinovič , Asbjørn Mack, Gisbert Selke, Angela Timoney, Ewa Warmińska, Rickard E Malmström

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)
97 Downloads (Pure)


The 3-day course on the managed introduction of new drugs was organised by the Piperska group together with the Agency for Health Technology Assessment and Tariff System (AOTMiT) and WHO Europe to share experiences and case histories among health authority and health insurance company personnel, academics and those from commercial organisations from across Europe on potential ways to optimise the managed entry of new medicines. This starts pre-launch with horizon scanning and budgeting, then peri-launch including critical drug evaluation, and finally post launch including monitoring prescribing of new medicines against agreed guidance and indicators. There were also discussions on issues regarding managed entry schemes and procurement strategies including biosimilars.
Original languageEnglish
Pages (from-to)755-758
Number of pages4
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Issue number5
Publication statusPublished - 14 Sep 2015


  • biosimilars
  • horizon scanning
  • managed entry schemes
  • medicines

Cite this